Drugmaker Merck buys innovator Harrisvaccines

Merck Animal Health, part of global pharmaceutical giant Merck, is buying privately owned Harrisvaccines, the companies said in a joint announcement. Merck said it has a “robust portfolio of vaccines across all animal species” and Harrisvaccines’ specialty of vaccines for food-bearing animals and pets would strengthen the Merck line. Harrisvaccines was the first company to… » Read More

The Ag Insider content is only available to members.